458 related articles for article (PubMed ID: 32443967)
1. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma.
Benadon B; Servagi-Vernat S; Quero L; Cattan P; Guillerm S; Hennequin V; Aparicio T; Lourenço N; Bouché O; Hennequin C
Dig Liver Dis; 2020 Sep; 52(9):1047-1052. PubMed ID: 32493629
[TBL] [Abstract][Full Text] [Related]
4. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
5. Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment.
Bongers MER; Groot OQ; Buckless CG; Kapoor ND; Twining PK; Schwab JH; Torriani M; Bredella MA
Spine J; 2022 Apr; 22(4):595-604. PubMed ID: 34699994
[TBL] [Abstract][Full Text] [Related]
6. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
[TBL] [Abstract][Full Text] [Related]
7. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
[TBL] [Abstract][Full Text] [Related]
8. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
Zouhry Y; Taibi A; Durand-Fontanier S; Darbas T; Forestier G; Monteil J; Lebrun-Ly V; Fayemendy P; Leobon S; Jesus P; Deluche E
BMC Cancer; 2021 Dec; 21(1):1313. PubMed ID: 34876055
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC.
Mallet R; Decazes P; Modzelewski R; Lequesne J; Vera P; Dubray B; Thureau S
Sci Rep; 2021 May; 11(1):10628. PubMed ID: 34017035
[TBL] [Abstract][Full Text] [Related]
10. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Smee R; Moses D; Bauer J
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
[TBL] [Abstract][Full Text] [Related]
11. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
[TBL] [Abstract][Full Text] [Related]
12. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
13. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
Özkul B; Özkul Ö; Bilir C
Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
15. Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis.
Keshoofi P; Schindler P; Rennebaum F; Cordes F; Morgul H; Wildgruber M; Heinzow HS; Pascher A; Schmidt HH; Hüsing-Kabar A; Praktiknjo M; Trebicka J; Seifert LL
BMC Gastroenterol; 2024 Apr; 24(1):145. PubMed ID: 38664624
[TBL] [Abstract][Full Text] [Related]
16. Influence of sarcopenia, clinical data, and 2-[
Anconina R; Ortega C; Metser U; Liu ZA; Suzuki C; McInnis M; Darling GE; Wong R; Taylor K; Yeung J; Chen EX; Swallow CJ; Bajwa J; Jang RW; Elimova E; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1012-1020. PubMed ID: 34491404
[TBL] [Abstract][Full Text] [Related]
17. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.
Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H
Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182
[TBL] [Abstract][Full Text] [Related]
18. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
Huang CY; Sun FJ; Lee J
Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
[TBL] [Abstract][Full Text] [Related]
20. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
